Cardiomyopathy is a term used for diseases of the heart muscle, where the walls of the heart chambers have become stretched, thickened or stiff. This affects the heart’s ability to pump blood around the body. There are different types of cardiomyopathies known as dilated, hypertrophic, restrictive, arrhythmogenic right ventricular, etc. Cardiomyopathies arise from a complex […]
A new Imperial centre will pioneer research to optimise how antimicrobial drugs are used to both improve patient care and preserve antibiotics Led by Professor Alison Holmes, the Centre for Antimicrobial Optimisation (CAMO) will support and deliver innovative technologies to optimise the use of antibiotics, antifungals and antivirals to improve patient care and reduce the drivers […]
PartnershipTherapeutic Initiative to increase access to expensive hepatitis drugs in poorer countries
An initiative to improve access to high-cost hepatitis C treatments in poorer countries has resulted in more people being treated for the disease. A collaborative study from Imperial College Business School and Imperial’s Department of Medicine, addressed the impact of voluntary licences to overcome price challenges of hepatitis C drugs. Voluntary licenses are issued with permission of […]
For World Hepatitis Day (28 July), Dr Philippa Pristerà shared an open letter to the people that she met and interviewed early last year as part of her research study exploring the experiences of people living with and accessing care for hepatitis C, and their perspectives on cure. Dr Pristerà is a research associate in […]
DiagnosticInnovationPrevention Pancreatic architecture provides insights into the genetics of type 2 diabetes
NIHR Imperial BRC investigators have worked out how the genome is folded in pancreatic insulin-producing cells, and used this knowledge to create tissue-specific risk scores for type 2 diabetes. Type 2 diabetes (T2D) is a polygenic disease that causes the level of sugar (glucose) in the blood to become too high. T2D occurs when the […]
EventTraining Healthcare professionals who stepped into research celebrate 10 years of pioneering scheme
Imperial marked the 10th anniversary of an innovative programme to encourage hospital staff to get involved in research at a special event last week More than 60 staff from Imperial College London, Imperial College Healthcare NHS Trust, The Royal Marsden NHS Foundation Trust and the Royal Brompton NHS Foundation Trust gathered at Imperial’s South Kensington […]
The NIHR Imperial BRC has been supporting projects via the Institute for Translational Medicine and Therapeutics (ITMAT) scheme since 2015. This scheme aims to support projects that are highly likely to lead to a benefit for patients in Imperial College Healthcare NHS Trust, and/or follow-on funding or high impact publications. Over 4 previous rounds, a […]
Harnessing world-leading discovery science and clinical expertise to develop innovative therapeutics, devices and diagnostics for healthcare
Examples of research projects testing out new drugs, devices and diagnostics in humans for the first time. The BRC is specifically aimed at supporting these kinds of experimental medicine studies.
The NIHR Imperial BRC has developed a range of innovative device technologies, in collaboration with scientists in our Faculties of Natural Sciences and Engineering. Some of the most recent are highlighted here.
The NIHR Imperial BRC has a strong, successful track record of collaborating with life sciences and other related industries, academic institutions, charities and research organisations. Most recent examples can be found here.